Efficacy and safety of the 200โ300 mg su
โ
B. Trimarco; D. Radzik; E. Neveux; A. Wajman; P. Attali; W. Mieghem; J. Ponsonna
๐
Article
๐
1995
๐
Springer
๐
English
โ 371 KB
The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59